These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6296016)

  • 1. Ceftizoxime: collaborative multiphased in-vitro evaluation including tentative interpretive standards for disc susceptibility tests, beta-lactamase stability, and inhibition.
    Barry AL; Jones RN; Thornsberry C; Fuchs PC; Gerlach EH; Sommers HM
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():25-44. PubMed ID: 6296016
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergism and antagonism of ceftizoxime and other new cephalosporins.
    Moellering RC; Willey S; Eliopoulos GM
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():69-79. PubMed ID: 6296032
    [No Abstract]   [Full Text] [Related]  

  • 3. Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteria.
    Fuchs PC; Jones RN; Thornsberry C; Barry AL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1981 Dec; 20(6):747-59. PubMed ID: 6275784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activity of ceftizoxime and four other cephalosporins against gram negative bacteria and their sensitivity to beta-lactamases.
    Esposito S; Galante D; Barba D; Pennucci C; Limauro D
    Microbiologica; 1985 Apr; 8(2):197-204. PubMed ID: 3874342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cooperation of cefotaxime and desacetyl-cefotaxime with respect to antibacterial activity and beta-lactamase stability.
    Limbert M; Seibert G; Schrinner E
    Infection; 1982; 10(2):97-100. PubMed ID: 6284653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative beta-lactamase hydrolysis of and inhibition by 7-aminothiazolyl alpha-methoxyimino cephalosporins.
    Jones RN; Wilson HW
    Infection; 1982; 10(5):303-6. PubMed ID: 6293977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Review [New antibiotics series VI]: Ceftizoxime (author's transl)].
    Shimizu K; Shimada J
    Jpn J Antibiot; 1982 Apr; 35(4):869-83. PubMed ID: 6285027
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro antimicrobial activity of ceftizoxime.
    Schell RF; LeFrock JL; Smith BR; Francisco M
    Chemotherapy; 1983; 29(6):408-14. PubMed ID: 6317295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro microbiological properties of mezlocillin compared with four cephalosporins.
    Esposito S; Galante D; Barba D
    Chemioterapia; 1986 Aug; 5(4):273-7. PubMed ID: 3490314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.
    Jayahar Bharathi M; Ramakrishnan R; Ramesh S; Murugan N
    Ophthalmic Res; 2012; 47(1):52-6. PubMed ID: 21720185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative activity of ceftizoxime against aminoglycoside-resistant aerobic gram-negative bacilli.
    Gómez-Lus R; Rubio MC; García C; Gómez-Lus ML; Alejandre MC
    Drugs Exp Clin Res; 1987; 13(3):155-9. PubMed ID: 3497792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antibacterial activity and beta-lactamase stability of CL 118523, an aminothiazolyl iminomethoxy cephalosporin.
    Chin NX; Neu HC
    Chemioterapia; 1987 Oct; 6(5):329-36. PubMed ID: 3322588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in-vitro activity and beta-lactamase stability of carumonam.
    Neu HC; Chin NX; Labthavikul P
    J Antimicrob Chemother; 1986 Jul; 18(1):35-44. PubMed ID: 3531143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M; Grehn M; Wundt W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacteroides and beta-lactamase inhibitory activities of moxalactam.
    Fu KP; Neu HC
    J Antimicrob Chemother; 1981 Oct; 8(4):337-41. PubMed ID: 6271727
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical laboratory approach for estimating effective administrative dose of ceftizoxime. Observation from MIC and ceftizoxime disc susceptibility test].
    Uete T; Matsuo K
    Jpn J Antibiot; 1987 Feb; 40(2):331-9. PubMed ID: 3474430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro evaluation of Sch 34343: antimicrobial activity, beta-lactamase stability and inhibition.
    Jones RN; Barry AL; Fuchs PC; Thornsberry C
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():99-109. PubMed ID: 3875606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activity of ceftizoxime in combination with gentamicin against hospital isolates of gentamicin-susceptible and resistant Gram-negative bacteria.
    Penn RL; King JW
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():51-5. PubMed ID: 6296029
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sensitivity, to cefotaxime (HR 756), of multiresistant bacteria and/or beta-lactamase producers].
    Andreoni O; Fonio P
    G Ital Chemioter; 1980; 27(1):49-55. PubMed ID: 6269937
    [No Abstract]   [Full Text] [Related]  

  • 20. Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism.
    Chin NX; Neu HC
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):21S-31S. PubMed ID: 6086215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.